[ Home | Contents | Search | Post | Reply | Next | Previous | Up ]
From: fyaodo
Date: 10/30/2007
Time: 12:43:11 AM
Remote Name: 209.205.196.2
Enlarged prostate symptoms rarely manifest before the age of 40. For some men, symptoms might not even occur at all. However, the condition called BPH or enlarged prostate affects almost 90 percent of men in their seventies and eighties, while more than 50 percent of men who reach their sixties experience symptoms. Benign Prostatic Hyperplasia (BPH) or Benign Prostatic Hypertrophy is a condition characterized by the enlargement of the prostate gland; a common occurrence since it is quite normal for mens prostates to enlarge as they age. The growth of the prostate has two main phases; the first is during puberty, when the size of the gland doubles; and the second is at around age 25, when the gland starts growing again. The second growth phase often results in BPH years later. Some of the more common enlarged prostate symptoms include weak stream of urine, difficulty in starting urination, dribbling and leaking of urine, a strong and sudden desire to urinate especially at night, a feeling of not emptying the ... | http://www.findpenisenlargement.info/prosolution-penile-enlargement-pills.html | http://www.findpenisenlargement.info/truth-about-pnis-enlargement.html | http://www.findpenisenlargement.info/penis-elargement-tool.html | http://www.findpenisenlargement.info/penis-elargement-cream.html | http://www.findpenisenlargement.info/pennis-enlargement-technique.html | http://www.findpenisenlargement.info/online-vigrx.html | http://www.findpenisenlargement.info/real-penis-enlargement.html | http://www.findpenisenlargement.info/prosolution-penis-enlargement-pill.html t PDE5 may serve as a molecular target for the treatment or prevention of the disorder. Dr. Burnett and his colleagues in Johns Hopkins University, Baltimore, USA focused on this hypothesis to carry out the path breaking research. The research team administered a long term PDE5 inhibitor treatment to three men with priapism due to sickle cell disease and a man with complaint of recurrent idiopathic priapism. They were given 25 to 30 mg oral dosage of Sildenafil (Viagra) in the morning three times a week, for a long period of time. The patients were closely followed and examined for a period of three to eleven months, and it was found that the rate of occurrence of priapism gradually came down to very rare or occasional. The research team said that the encouraging results prove the dysregulated PDE5 hypothesis. It shows that this treatment resets the erectile regulatory function of PDE5 back to normal and protects the penis from episodes of priapism. The revolutionary research defies conventional wisdom and ju ...